In this context, Foxy-5 was able to impair the motility of breast cancer cell lines with low levels of endogenous WNT-5A [175] and to reduce the early metastatic spread of WNT-5A-low prostate cancer cells in an orthotopic mouse model [176]. This evidence concerns the gene WNT5A and Familial prostate cancer.